ULTIVA Side Effects

6986097-3 | Altered State Of Consciousness, Central-alveolar Hypoventilation, Overdose, Post Procedural Complication, Respiratory Depression
on Aug 30, 2010 Male patient from FRANCE , 27 years of age, was treated with Ultiva (View Usage). Patient experienced the following unwanted or unexpected effects: altered state of consciousness, central-alveolar hypoventilation, overdose, post procedural complication, respiratory depression. Ultiva dosage: Iv. During the same period patient was treated with PROPOFOL (View Propofol Review and Propofol Label ), METHADONE (View Methadone Review and Methadone Label ).

6943449-5 | Decerebration, Discomfort, Electrocardiogram Qrs Complex Shortened, Gaze Palsy, Heart Rate Decreased, Hypertension, Hypoxia, Mucosal Discolouration
Patient was taking Ultiva (View Usage). Patient had the following side effects: decerebration, discomfort, electrocardiogram qrs complex shortened, gaze palsy, heart rate decreased, hypertension, hypoxia, mucosal discolouration on Aug 03, 2010 from SPAIN Additional patient health information: Male patient , 59 years of age, was diagnosed with surgery (What is surgery?) and. Ultiva dosage: 0.1 Mcg/kg. During the same period patient was treated with MIDAZOLAM (NO PREF. NAME) (1.5 Mg;x1) (View Midazolam (no Pref. Name) Review and Midazolam (no Pref. Name) Label ), PROPOFOL (1 Mg/kg.hr ; 50 Mg;x1) (View Propofol Review and Propofol Label ), CON MEDS (View Con Meds Review and Con Meds Label ), PREV MEDS (View Prev Meds Review and Prev Meds Label ).

6942079-9 | No Therapeutic Response, Trismus
Adverse event was reported on Aug 11, 2010 by a Female patient taking Ultiva (View Usage) (Dosage: 0.29 Mg/kg/hr; ; Iv) . Location: GERMANY , 54 years of age, After Ultiva was administered, patient had the following side effects: no therapeutic response, trismus. During the same period patient was treated with PROPOFOL (2.5 Mg/kg; X1; Iv) (View Propofol Review and Propofol Label ), BETA 2 ADRENERGIC (View Beta-2 Adrenergic Review and Beta-2 Adrenergic Label ), AGONIST INHALANTS INHALATIVE (View Agonist Inhalants Inhalative Review and Agonist Inhalants Inhalative Label ), CORTICOSTEROIDS (View Corticosteroids Review and Corticosteroids Label ), CLOMIPRAMINE (View Clomipramine Review and Clomipramine Label ).

6869539-3 | Decerebration, Discomfort, Hypertension, Hypoxia, Infusion Related Reaction
on Jul 08, 2010 Male patient from SPAIN , 59 years of age, was diagnosed with surgery (What is surgery?) and was treated with Ultiva (View Usage). Patient experienced the following unwanted or unexpected effects: decerebration, discomfort, hypertension, hypoxia, infusion related reaction. Ultiva dosage: 0.1 Mcg/kg;. During the same period patient was treated with MIDAZOLAM (NO PREF. NAME) (1.5 Mg;x1) (View Midazolam (no Pref. Name) Review and Midazolam (no Pref. Name) Label ), PROPOFOL (1 Mg/kg/hr; 50 Mg;x1) (View Propofol Review and Propofol Label ).


6846913-2 | Cardiac Arrest, Procedural Complication
on Jun 30, 2010 Female patient from JAPAN , 66 years of age, weighting 99.21 lb, was diagnosed with induction of anaesthesia, hypertension and was treated with Ultiva (View Usage). Patient had the following side effects: cardiac arrest (What is cardiac arrest?), procedural complication. Ultiva dosage: 0.25 Mcg/kg/min; Iv; 2 0.3 Mcg/kg/min; Iv. During the same period patient was treated with ATENOLOL (50 Mg;qd) (View Atenolol Review and Atenolol Label ), PROPOFOL (View Propofol Review and Propofol Label ), ROCURONTUM (View Rocurontum Review and Rocurontum Label ), OXYGEN (View Oxygen Review and Oxygen Label ), SEVOFLURANE (View Sevoflurane Review and Sevoflurane Label ).

6754954-9 | Bradycardia, Cardiac Arrest, Procedural Complication
Patient was taking Ultiva (View Usage). After Ultiva was administered, patient had the following side effects: bradycardia, cardiac arrest (What is cardiac arrest?), procedural complication on May 24, 2010 from JAPAN Additional patient health information: Male patient , 48 years of age, was diagnosed with anaesthesia and. Ultiva dosage: . During the same period patient was treated with PROPOFOL (View Propofol Review and Propofol Label ), VECURONIUM BROMIDE (View Vecuronium Bromide Review and Vecuronium Bromide Label ).

6754953-7 | Cardiac Arrest, Heart Rate Decreased
Adverse event was reported on May 24, 2010 by a Female patient taking Ultiva (View Usage) (Dosage: ) was diagnosed with anaesthesia and. Location: JAPAN , 52 years of age, Patient experienced the following unwanted or unexpected effects: cardiac arrest (What is cardiac arrest?), heart rate decreased. During the same period patient was treated with PROPOFOL (View Propofol Review and Propofol Label ), VECURONIUM BROMIDE (View Vecuronium Bromide Review and Vecuronium Bromide Label ).

6694820-0 | Airway Complication Of Anaesthesia, Arteriospasm Coronary, Blood Pressure Decreased, Coronary Artery Stenosis, Electrocardiogram St Segment Elevation, Heart Rate Decreased, Myocardial Ischaemia, Resuscitation, Ventricular Fibrillation
on Apr 09, 2010 Male patient from KOREA, REPUBLIC OF , 56 years of age, weighting 136.4 lb, was diagnosed with maintenance of anaesthesia and was treated with Ultiva (View Usage). Patient had the following side effects: airway complication of anaesthesia, arteriospasm coronary, blood pressure decreased, coronary artery stenosis, electrocardiogram st segment elevation, heart rate decreased, myocardial ischaemia, resuscitation, ventricular fibrillation. Ultiva dosage: 0.25 Ug/kg/min. During the same period patient was treated with SEVOFLURANE (2-3% Vol%, Inhalation) (View Sevoflurane Review and Sevoflurane Label ), ACEBROPHYLLINE (View Acebrophylline Review and Acebrophylline Label ), MONTELUKAST SODIUM (View Montelukast Sodium Review and Montelukast Sodium Label ), MICRONIZED BUDESONIDE TURBUHALER WITH FORMOTEROL FUMARATE DIHYDRATE (View Micronized Budesonide Turbuhaler With Formoterol Fumarate Dihydrate Review and Micronized Budesonide Turbuhaler With Formoterol Fumarate Dihydrate Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ), GLYCOPYRROLATE (View Glycopyrrolate Review and Glycopyrrolate Label ), PROPOFOL (View Propofol Review and Propofol Label ), ROCURONIUM BROMIDE (View Rocuronium Bromide Review and Rocuronium Bromide Label ).

6670270-8 | Bacteraemia, Hyperthermia Malignant, Metabolic Acidosis
on Mar 22, 2010 Female patient from JAPAN , 87 years of age, was diagnosed with anaesthesia and was treated with Ultiva (View Usage). After Ultiva was administered, patient had the following side effects: bacteraemia, hyperthermia malignant, metabolic acidosis. Ultiva dosage: See Image. During the same period patient was treated with SEVOFRANE (SEVOFLURANE) LIQUID FOR INHALATION (See Image) (View Sevofrane (sevoflurane) Liquid For Inhalation Review and Sevofrane (sevoflurane) Liquid For Inhalation Label ), MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ), ROCURONIUM BROMIDE (View Rocuronium Bromide Review and Rocuronium Bromide Label ), FENTANYL 100 (View Fentanyl-100 Review and Fentanyl-100 Label ).

6657715-4 | Chills, Hyperthermia Malignant, Musculoskeletal Stiffness, Myotonia, Pyrexia
Patient was taking Ultiva (View Usage). Patient experienced the following unwanted or unexpected effects: chills, hyperthermia malignant, musculoskeletal stiffness, myotonia, pyrexia on Mar 25, 2010 from JAPAN Additional patient health information: Male patient , weighting 127.9 lb, was diagnosed with induction and maintenance of anaesthesia, hypotonia and. Ultiva dosage: 0.05-0.5 Mcg/kg/minx4hrs.(continuous Administration). During the same period patient was treated with SEVOFLURANE (1.5%x4.5hrs.(continuous Administration)) (View Sevoflurane Review and Sevoflurane Label ), FENTANYL (View Fentanyl Review and Fentanyl Label ), MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ), ROCURONIUM BROMIDE (View Rocuronium Bromide Review and Rocuronium Bromide Label ).

6646611-4 | Chills, Hyperthermia Malignant, Musculoskeletal Stiffness, Myotonia, Pyrexia
Adverse event was reported on Mar 19, 2010 by a Male patient taking Ultiva (View Usage) (Dosage: 0.05-0.5 Mcg/kg/minx4hrs.(continuous Administration)) was diagnosed with induction and maintenance of anaesthesia, hypotonia and. Location: JAPAN , weighting 127.9 lb, Patient had the following side effects: chills, hyperthermia malignant, musculoskeletal stiffness, myotonia, pyrexia. During the same period patient was treated with SEVOFLURANE (1.5%x4.5hrs.(continuous Administration)) (View Sevoflurane Review and Sevoflurane Label ), FENTANYL (View Fentanyl Review and Fentanyl Label ), MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ), ROCURONIUM BROMIDE (View Rocuronium Bromide Review and Rocuronium Bromide Label ).

6643515-8 | Bacteraemia, Chills, Hyperthermia Malignant, Metabolic Acidosis, Musculoskeletal Stiffness, Myotonia, Pyrexia
on Mar 15, 2010 Male patient from JAPAN , weighting 127.9 lb, was diagnosed with induction and maintenance of anaesthesia, hypotonia and was treated with Ultiva (View Usage). After Ultiva was administered, patient had the following side effects: bacteraemia, chills, hyperthermia malignant, metabolic acidosis, musculoskeletal stiffness, myotonia, pyrexia. Ultiva dosage: 0.05-0.5 Mcg/kg/minx4hrs.(continuous Administration). During the same period patient was treated with SEVOFLURANE (1.5%x4.5hrs.(continuous Administration)) (View Sevoflurane Review and Sevoflurane Label ), FENTANYL (View Fentanyl Review and Fentanyl Label ), MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ), ROCURONIUM BROMIDE (View Rocuronium Bromide Review and Rocuronium Bromide Label ).

6525701-0 | Angle Closure Glaucoma
on Dec 14, 2009 Female patient from JAPAN , 56 years of age, weighting 134.2 lb, was diagnosed with induction of anaesthesia, polyuria and was treated with Ultiva (View Usage). Patient experienced the following unwanted or unexpected effects: angle closure glaucoma. Ultiva dosage: Intravenous. During the same period patient was treated with FORANE (0.6-0.8%,) (View Forane Review and Forane Label ), ROCURONIUM BROMIDE (View Rocuronium Bromide Review and Rocuronium Bromide Label ), FENTANYL CITRATE (4 Ml, 2 In 1 D, Intravenous) (View Fentanyl Citrate Review and Fentanyl Citrate Label ), MANNITOL (300 Ml, 1 In 1 D,) (View Mannitol Review and Mannitol Label ), MEPIVACAINE HCL (3 Ml, 1 In 1 D,) (View Mepivacaine Hcl Review and Mepivacaine Hcl Label ), PROTAMINE SULFATE (3 Ml, 1 In 1 D,) (View Protamine Sulfate Review and Protamine Sulfate Label ), ATVAGOREVERSE (6 Ml, 1 In 1 D, Intravenous) (View Atvagoreverse Review and Atvagoreverse Label ), PROPOFOL (70 Mg, Intravenous) (View Propofol Review and Propofol Label ).

6438128-7 | Anaesthetic Complication, Blood Pressure Immeasurable, Torsade De Pointes, Ventricular Arrhythmia
Patient was taking Ultiva (View Usage). Patient had the following side effects: anaesthetic complication, blood pressure immeasurable, torsade de pointes, ventricular arrhythmia on Oct 27, 2009 from JAPAN Additional patient health information: Female patient , 80 years of age, weighting 121.0 lb, was diagnosed with anaesthesia, maintenance of anaesthesia, induction of anaesthesia and. Ultiva dosage: . During the same period patient was treated with SEVOFLURANE (View Sevoflurane Review and Sevoflurane Label ), ATROPINE (0.5 Mg, Intravenous) (View Atropine Review and Atropine Label ), THIAMYLAL (View Thiamylal Review and Thiamylal Label ), ROCURONIUM BROMIDE (View Rocuronium Bromide Review and Rocuronium Bromide Label ), OXYGEN (View Oxygen Review and Oxygen Label ).

6427866-8 | Blood Pressure Immeasurable, Torsade De Pointes
Adverse event was reported on Oct 15, 2009 by a Female patient taking Ultiva (View Usage) (Dosage: ) was diagnosed with anaesthesia, maintenance of anaesthesia, induction of anaesthesia and. Location: JAPAN , 80 years of age, weighting 121.0 lb, After Ultiva was administered, patient had the following side effects: blood pressure immeasurable, torsade de pointes. During the same period patient was treated with SEVOFLURANE (Inhalation) (View Sevoflurane Review and Sevoflurane Label ), ATROPINE (0.5 Mg, Intravenous) (View Atropine Review and Atropine Label ), THIAMYLAL (View Thiamylal Review and Thiamylal Label ), ROCURONIUM BROMIDE (View Rocuronium Bromide Review and Rocuronium Bromide Label ), OXYGEN (View Oxygen Review and Oxygen Label ).

6408104-9 | Blood Pressure Diastolic Decreased, Bradycardia, Bundle Branch Block
on Oct 04, 2009 Female patient from JAPAN , 17 years of age, was diagnosed with anaesthesia and was treated with Ultiva (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure diastolic decreased, bradycardia, bundle branch block. Ultiva dosage: 0.15 Mcg/kg/min, Continuous, Intravenous. During the same period patient was treated with SEVOFLURANE (1.5-2.0%, Continuous, Inhalation) (View Sevoflurane Review and Sevoflurane Label ), PROPOFOL (View Propofol Review and Propofol Label ), VECURONIUM BROMIDE (View Vecuronium Bromide Review and Vecuronium Bromide Label ).

6389046-4 | Hyperhidrosis, Hypertension, Muscle Twitching, Mydriasis, Rhinorrhoea, Tachycardia
on Sep 16, 2009 Male patient from JAPAN , 58 years of age, weighting 116.6 lb, was diagnosed with insomnia and was treated with Ultiva (View Usage). Patient had the following side effects: hyperhidrosis, hypertension, muscle twitching, mydriasis, rhinorrhoea, tachycardia. Ultiva dosage: . During the same period patient was treated with BUTORPHANOL TARTRATE (0.12 Mg/hr;) (View Butorphanol Tartrate Review and Butorphanol Tartrate Label ), MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ).

6369303-8 | Fall, Heart Rate Decreased, Humerus Fracture, Hypotension
Patient was taking Ultiva (View Usage). After Ultiva was administered, patient had the following side effects: fall (What is fall?), heart rate decreased, humerus fracture, hypotension on Sep 02, 2009 from JAPAN Additional patient health information: Female patient , 76 years of age, was diagnosed with anaesthesia, depression (What is depression?) and. Ultiva dosage: 0.05 To 0.25 Mcg/kg/min. During the same period patient was treated with AMITRIPTYLINE HCL (75 Mg Daily, Oral 6 Years Prior) (View Amitriptyline Hcl Review and Amitriptyline Hcl Label ), PROPOFOL (40 Mg/kg, Intravenous) (View Propofol Review and Propofol Label ), SEVOFLURANE (1.5%, Inhalation) (View Sevoflurane Review and Sevoflurane Label ), VECURONIUM BROMIDE (View Vecuronium Bromide Review and Vecuronium Bromide Label ).

6335596-6 | Blood Pressure Systolic Increased, Fall, Haemorrhage, Heart Rate Decreased, Humerus Fracture, Hypotension
Adverse event was reported on Aug 11, 2009 by a Female patient taking Ultiva (View Usage) (Dosage: 0.05 To 0.25 Mcg/kg/min) was diagnosed with anaesthesia, depression (What is depression?) and. Location: JAPAN , 78 years of age, Patient experienced the following unwanted or unexpected effects: blood pressure systolic increased, fall (What is fall?), haemorrhage, heart rate decreased, humerus fracture, hypotension. During the same period patient was treated with PROPOFOL (40 Mg/kg, Intravenous) (View Propofol Review and Propofol Label ), SEVOFLURANE (1.5%, Inhalation) (View Sevoflurane Review and Sevoflurane Label ), VECHRONIUM (View Vechronium Review and Vechronium Label ).

6287425-7 | Blood Pressure Systolic Increased, Fall, Heart Rate Decreased, Humerus Fracture, Hypotension
on Jul 15, 2009 Female patient from JAPAN , 76 years of age, was diagnosed with anaesthesia, depression (What is depression?) and was treated with Ultiva (View Usage). Patient had the following side effects: blood pressure systolic increased, fall (What is fall?), heart rate decreased, humerus fracture, hypotension. Ultiva dosage: 0.05 To 0.25 Mcg/kg/min,. During the same period patient was treated with PROPOFOL (40 Mg/kg, Intravenous) (View Propofol Review and Propofol Label ), VECURONIUM BROMIDE (View Vecuronium Bromide Review and Vecuronium Bromide Label ).

6260852-X | Respiratory Depression, Urine Output Decreased
on Jun 18, 2009 Male patient from JAPAN , 52 years of age, weighting 85.80 lb, was diagnosed with anaesthesia and was treated with Ultiva (View Usage). After Ultiva was administered, patient had the following side effects: respiratory depression, urine output decreased. Ultiva dosage: 0.1-0.15 Mcg/kg/minute, Intravenous. During the same period patient was treated with LIDOCAINE (View Lidocaine Review and Lidocaine Label ), PROPOFOL (View Propofol Review and Propofol Label ), SEVOFLURANE (View Sevoflurane Review and Sevoflurane Label ), DOPAMINE HCL (View Dopamine Hcl Review and Dopamine Hcl Label ), OXYGEN (View Oxygen Review and Oxygen Label ), ROPIVACAINE (View Ropivacaine Review and Ropivacaine Label ), NALOXONE (View Naloxone Review and Naloxone Label ).

6204474-5 | Blood Pressure Decreased, Blood Pressure Increased, Fall, Heart Rate Decreased, Humerus Fracture
Patient was taking Ultiva (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure decreased, blood pressure increased, fall (What is fall?), heart rate decreased, humerus fracture on May 05, 2009 from JAPAN Additional patient health information: Female patient , 76 years of age, was diagnosed with induction of anaesthesia, depression (What is depression?) and. Ultiva dosage: 0.05 To 0.25mcg/kg/min. During the same period patient was treated with AMITRIPTLINE HYDROCHLORIDE TAB (75 Mg, Daily, Oral/6 Years Prior) (View Amitriptline Hydrochloride Tab Review and Amitriptline Hydrochloride Tab Label ), PROPOFOL (View Propofol Review and Propofol Label ), VECURONIUM BROMIDE (View Vecuronium Bromide Review and Vecuronium Bromide Label ).

6179000-X | Procedural Pain
Adverse event was reported on Apr 17, 2009 by a Male patient taking Ultiva (View Usage) (Dosage: 11,860 Mcg Total, Intravenous) was diagnosed with induction of anaesthesia and. Location: UNITED STATES , 16 years of age, weighting 378.3 lb, Patient had the following side effects: procedural pain. During the same period patient was treated with FENTANYL (View Fentanyl Review and Fentanyl Label ), OXYCODONE HCL (View Oxycodone Hcl Review and Oxycodone Hcl Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), PROPOFOL (View Propofol Review and Propofol Label ), ROCURONIUM BROMIDE (View Rocuronium Bromide Review and Rocuronium Bromide Label ), BUPIVACAINE (View Bupivacaine Review and Bupivacaine Label ), DESFLURANE (View Desflurane Review and Desflurane Label ), MORPHINE (View Morphine Review and Morphine Label ).

6115096-9 | Tremor
on Mar 06, 2009 Female patient from NORWAY , 38 years of age, was diagnosed with prophylaxis and was treated with Ultiva (View Usage). After Ultiva was administered, patient had the following side effects: tremor. Ultiva dosage: .4mgkm Per Day. During the same period patient was treated with ONDANSETRON (8mg Per Day) (View Ondansetron Review and Ondansetron Label ), PROPOFOL (View Propofol Review and Propofol Label ). Patient was hospitalized.

5937477-6 | Injection Site Pain, Venous Thrombosis
on Oct 27, 2008 Female patient from NETHERLANDS , 55 years of age, weighting 167.6 lb, was treated with Ultiva (View Usage). Patient experienced the following unwanted or unexpected effects: injection site pain, venous thrombosis. Ultiva dosage: . During the same period patient was treated with CLINDAMYCINE (View Clindamycine Review and Clindamycine Label ), DIPRIVAN (View Diprivan Review and Diprivan Label ), LIDOCAINE (View Lidocaine Review and Lidocaine Label ), CEFUROXIME (View Cefuroxime Review and Cefuroxime Label ). Patient was hospitalized.

5935587-0 | Blister, Erythema Multiforme, Toxic Skin Eruption
Patient was taking Ultiva (View Usage). Patient had the following side effects: blister, erythema multiforme, toxic skin eruption on Oct 27, 2008 from JAPAN Additional patient health information: Male patient , 24 years of age, weighting 138.9 lb, was diagnosed with infection prophylaxis, hypotonia and. Ultiva dosage: 2mg Per Day. During the same period patient was treated with CEFAZOLIN SODIUM (2g Per Day) (View Cefazolin Sodium Review and Cefazolin Sodium Label ), THIOPENTAL SODIUM (.3g Per Day) (View Thiopental Sodium Review and Thiopental Sodium Label ), VECURONIUM BROMIDE (10mg Per Day) (View Vecuronium Bromide Review and Vecuronium Bromide Label ), NEOSTIGMINE BROMIDE (.5mg Per Day) (View Neostigmine Bromide Review and Neostigmine Bromide Label ), ATROPINE SULFATE (.5mg Per Day) (View Atropine Sulfate Review and Atropine Sulfate Label ). Patient was hospitalized.

5928099-1 | Anaphylactic Reaction, Blood Pressure Decreased, Erythema
Adverse event was reported on Oct 20, 2008 by a Male patient taking Ultiva (View Usage) (Dosage: ) . Location: JAPAN , 59 years of age, After Ultiva was administered, patient had the following side effects: anaphylactic reaction, blood pressure decreased, erythema. During the same period patient was treated with PROPOFOL (View Propofol Review and Propofol Label ), ROCURONIUM BROMIDE (View Rocuronium Bromide Review and Rocuronium Bromide Label ), CEFAMEZIN (View Cefamezin Review and Cefamezin Label ).

5853955-2 | Anaphylactic Reaction, Hypotension
on Aug 19, 2008 Female patient from FRANCE , 61 years of age, was diagnosed with perioperative analgesia and was treated with Ultiva (View Usage). Patient experienced the following unwanted or unexpected effects: anaphylactic reaction, hypotension. Ultiva dosage: . During the same period patient was treated with DIPRIVAN (View Diprivan Review and Diprivan Label ), CELOCURINE (View Celocurine Review and Celocurine Label ), CEFAZOLIN (View Cefazolin Review and Cefazolin Label ), PERFALGAN (View Perfalgan Review and Perfalgan Label ), ACUPAN (View Acupan Review and Acupan Label ), PROFENID (View Profenid Review and Profenid Label ). Patient was hospitalized.

5848195-7 | Anaphylactic Reaction
on Aug 11, 2008 Female patient from JAPAN , 72 years of age, weighting 83.78 lb, was diagnosed with head and neck cancer (What is head and neck cancer?) and was treated with Ultiva (View Usage). Patient had the following side effects: anaphylactic reaction. Ultiva dosage: . During the same period patient was treated with PROPOFOL (80mg Per Day) (View Propofol Review and Propofol Label ), ROCURONIUM BROMIDE (30mg Per Day) (View Rocuronium Bromide Review and Rocuronium Bromide Label ), SEVOFLURANE (View Sevoflurane Review and Sevoflurane Label ), RASENAZOLIN (1g Per Day) (View Rasenazolin Review and Rasenazolin Label ). Patient was hospitalized.

5841828-0 | Anaphylactic Reaction, Blood Pressure Decreased, Bronchospasm, Tryptase Increased
Patient was taking Ultiva (View Usage). After Ultiva was administered, patient had the following side effects: anaphylactic reaction, blood pressure decreased, bronchospasm, tryptase increased on Aug 08, 2008 from FRANCE Additional patient health information: Female patient , 43 years of age, was diagnosed with preoperative care and. Ultiva dosage: . During the same period patient was treated with CEFAZOLIN (2g Single Dose) (View Cefazolin Review and Cefazolin Label ), TAGAMET (200mg Single Dose) (View Tagamet Review and Tagamet Label ), ATARAX (100mg Single Dose) (View Atarax Review and Atarax Label ), XANAX (.25mg Single Dose) (View Xanax Review and Xanax Label ), DIPRIVAN (View Diprivan Review and Diprivan Label ), CELOCURINE (View Celocurine Review and Celocurine Label ). Patient was hospitalized.

5840092-6 | Blister, Erythema Multiforme, Toxic Skin Eruption
Adverse event was reported on Aug 04, 2008 by a Male patient taking Ultiva (View Usage) (Dosage: 2mg Per Day) was diagnosed with infection prophylaxis and. Location: JAPAN , 24 years of age, Patient experienced the following unwanted or unexpected effects: blister, erythema multiforme, toxic skin eruption. During the same period patient was treated with CEFAZOLIN SODIUM (2g Per Day) (View Cefazolin Sodium Review and Cefazolin Sodium Label ), THIOPENTAL SODIUM (.3g Single Dose) (View Thiopental Sodium Review and Thiopental Sodium Label ), VECURONIUM BROMIDE (10mg Per Day) (View Vecuronium Bromide Review and Vecuronium Bromide Label ), NEOSTIGMINE BROMIDE (.5mg Per Day) (View Neostigmine Bromide Review and Neostigmine Bromide Label ), ATROPINE SULFATE (.5mg Per Day) (View Atropine Sulfate Review and Atropine Sulfate Label ). Patient was hospitalized.

5816200-X | Anaphylactic Reaction
on Jul 14, 2008 Female patient from JAPAN , 72 years of age, weighting 83.78 lb, was diagnosed with head and neck cancer (What is head and neck cancer?) and was treated with Ultiva (View Usage). Patient had the following side effects: anaphylactic reaction. Ultiva dosage: . During the same period patient was treated with PROPOFOL (80mg Per Day) (View Propofol Review and Propofol Label ), ROCURONIUM BROMIDE (30mg Per Day) (View Rocuronium Bromide Review and Rocuronium Bromide Label ), SEVOFLURANE (View Sevoflurane Review and Sevoflurane Label ), RASENAZOLIN (1g Per Day) (View Rasenazolin Review and Rasenazolin Label ). Patient was hospitalized.

5801718-6 | Anaphylactic Reaction, Blood Pressure Decreased, Bronchospasm, Tryptase Increased
on Jul 03, 2008 Female patient from FRANCE , 43 years of age, was diagnosed with preoperative care and was treated with Ultiva (View Usage). After Ultiva was administered, patient had the following side effects: anaphylactic reaction, blood pressure decreased, bronchospasm, tryptase increased. Ultiva dosage: . During the same period patient was treated with CEFAZOLIN (2g Single Dose) (View Cefazolin Review and Cefazolin Label ), TAGAMET (200mg Single Dose) (View Tagamet Review and Tagamet Label ), ATARAX (100mg Single Dose) (View Atarax Review and Atarax Label ), XANAX (.25mg Single Dose) (View Xanax Review and Xanax Label ), DIPRIVAN (View Diprivan Review and Diprivan Label ), CELOCURINE (View Celocurine Review and Celocurine Label ). Patient was hospitalized.

5757073-3 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Creatine Phosphokinase Increased, Blood Lactate Dehydrogenase Increased, Liver Disorder, Trigeminal Neuralgia
Patient was taking Ultiva (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood creatine phosphokinase increased, blood lactate dehydrogenase increased, liver disorder, trigeminal neuralgia (What is trigeminal neuralgia?) on May 23, 2008 from JAPAN Additional patient health information: Male patient , 73 years of age, weighting 112.4 lb, . Ultiva dosage: 4mg Per Day. During the same period patient was treated with CEFAZOLIN SODIUM (1g Per Day) (View Cefazolin Sodium Review and Cefazolin Sodium Label ), PROPOFOL (100mg Per Day) (View Propofol Review and Propofol Label ), SEVOFLURANE (80ml Per Day) (View Sevoflurane Review and Sevoflurane Label ), VECURONIUM BROMIDE (8mg Per Day) (View Vecuronium Bromide Review and Vecuronium Bromide Label ).

5728766-9 | Bone Marrow Failure, Hyperthermia, Hypotension, Lactic Acidosis, Lung Disorder, Respiratory Disorder, Septic Shock
Adverse event was reported on Apr 29, 2008 by a Female patient taking Ultiva (View Usage) (Dosage: ) . Location: FRANCE , 71 years of age, Patient had the following side effects: bone marrow failure, hyperthermia, hypotension, lactic acidosis, lung disorder, respiratory disorder, septic shock. During the same period patient was treated with ACETAMINOPHEN (1g Four Times Per Day) (View Acetaminophen Review and Acetaminophen Label ), MORPHINE (View Morphine Review and Morphine Label ), DIPRIVAN (View Diprivan Review and Diprivan Label ), DROLEPTAN (View Droleptan Review and Droleptan Label ).

5597599-9 | Anaphylactic Shock, Bronchospasm, Circulatory Collapse
on Jan 17, 2008 Male patient from FRANCE , 52 years of age, was treated with Ultiva (View Usage). After Ultiva was administered, patient had the following side effects: anaphylactic shock, bronchospasm, circulatory collapse. Ultiva dosage: . During the same period patient was treated with AUGMENTIN '125' (View Augmentin '125' Review and Augmentin '125' Label ), DIPRIVAN (View Diprivan Review and Diprivan Label ), XYLOCAINE (View Xylocaine Review and Xylocaine Label ). Patient was hospitalized.

5478395-X | Anaphylactoid Shock, Cyanosis, Heart Rate Increased, Hypotension, Oxygen Saturation Decreased, Urticaria
on Sep 28, 2007 Male patient from FRANCE , 69 years of age, was diagnosed with antibiotic prophylaxis and was treated with Ultiva (View Usage). Patient experienced the following unwanted or unexpected effects: anaphylactoid shock, cyanosis, heart rate increased, hypotension, oxygen saturation decreased, urticaria. Ultiva dosage: . During the same period patient was treated with DIPRIVAN (View Diprivan Review and Diprivan Label ), SEVORANE (View Sevorane Review and Sevorane Label ), AUGMENTIN '125' (2g Per Day) (View Augmentin '125' Review and Augmentin '125' Label ), LIPANTHYL (View Lipanthyl Review and Lipanthyl Label ), ZYLORIC (View Zyloric Review and Zyloric Label ), TENORETIC 100 (View Tenoretic 100 Review and Tenoretic 100 Label ), ATARAX (100mg Per Day) (View Atarax Review and Atarax Label ). Patient was hospitalized.

5412539-0 | Anaphylactic Shock, Hypotension, Mechanical Ventilation Complication, Tachycardia
Patient was taking Ultiva (View Usage). Patient had the following side effects: anaphylactic shock, hypotension, mechanical ventilation complication, tachycardia on Aug 08, 2007 from FRANCE Additional patient health information: Male patient , 60 years of age, was diagnosed with antibiotic prophylaxis and. Ultiva dosage: . During the same period patient was treated with TRACRIUM (40mg Per Day) (View Tracrium Review and Tracrium Label ), AMOXICILLIN AND CLAVULANATE POTASSIUM (View Amoxicillin And Clavulanate Potassium Review and Amoxicillin And Clavulanate Potassium Label ), DIPRIVAN (190mg Per Day) (View Diprivan Review and Diprivan Label ), SUPRANE (View Suprane Review and Suprane Label ).

5349328-1 | Myoclonus
Adverse event was reported on Jun 01, 2007 by a Male patient taking Ultiva (View Usage) (Dosage: ) was diagnosed with nasal septal operation, sedation and. Location: GERMANY , 26 years of age, After Ultiva was administered, patient had the following side effects: myoclonus. During the same period patient was treated with ATROPINE SULFATE (1mg Single Dose) (View Atropine Sulfate Review and Atropine Sulfate Label ), PROMETHAZINE (50mg Single Dose) (View Promethazine Review and Promethazine Label ), CLINDAMYCIN HCL (300mg Single Dose) (View Clindamycin Hcl Review and Clindamycin Hcl Label ), RANITIDINE (300mg Single Dose) (View Ranitidine Review and Ranitidine Label ), DORMICUM (3mg Per Day) (View Dormicum Review and Dormicum Label ), ULTRACAIN (5ml Four Times Per Day) (View Ultracain Review and Ultracain Label ), DICLOFENAC (100mg Single Dose) (View Diclofenac Review and Diclofenac Label ). Patient was hospitalized.

5303304-3 | Bloody Discharge, Coagulation Time Prolonged, International Normalised Ratio Increased, Kaolin Cephalin Clotting Time Prolonged
on Apr 12, 2007 Female patient from FRANCE , child 2 years of age, was diagnosed with antibiotic prophylaxis and was treated with Ultiva (View Usage). Patient experienced the following unwanted or unexpected effects: bloody discharge, coagulation time prolonged, international normalised ratio increased, kaolin cephalin clotting time prolonged. Ultiva dosage: 500mcg Per Day. During the same period patient was treated with AUGMENTIN '125' (View Augmentin '125' Review and Augmentin '125' Label ), KETAMINE HCL (1.5mg Per Day) (View Ketamine Hcl Review and Ketamine Hcl Label ), PERFALGAN (250mg Per Day) (View Perfalgan Review and Perfalgan Label ), HYPNOVEL (3mg Per Day) (View Hypnovel Review and Hypnovel Label ), MINI SINTROM (.25mg Per Day) (View Mini-sintrom Review and Mini-sintrom Label ), MORPHINE (3mg Per Day) (View Morphine Review and Morphine Label ), ZOPHREN (2mg Per Day) (View Zophren Review and Zophren Label ), NUBAIN (3mg Per Day) (View Nubain Review and Nubain Label ).

5293534-1 | Bloody Discharge, Coagulation Time Prolonged, International Normalised Ratio Increased, Kaolin Cephalin Clotting Time Prolonged
on Apr 04, 2007 Female patient from FRANCE , child 2 years of age, was diagnosed with antibiotic prophylaxis and was treated with Ultiva (View Usage). Patient had the following side effects: bloody discharge, coagulation time prolonged, international normalised ratio increased, kaolin cephalin clotting time prolonged. Ultiva dosage: 500g Per Day. During the same period patient was treated with AUGMENTIN '125' (View Augmentin '125' Review and Augmentin '125' Label ), KETAMINE HCL (1.5mg Per Day) (View Ketamine Hcl Review and Ketamine Hcl Label ), PERFALGAN (250mg Per Day) (View Perfalgan Review and Perfalgan Label ), HYPNOVEL (3mg Per Day) (View Hypnovel Review and Hypnovel Label ), MINI SINTROM (.25mg Per Day) (View Mini-sintrom Review and Mini-sintrom Label ), MORPHINE (3mg Per Day) (View Morphine Review and Morphine Label ), ZOPHREN (2mg Per Day) (View Zophren Review and Zophren Label ), NUBAIN (3mg Per Day) (View Nubain Review and Nubain Label ).

4877567-2 | Eyelid Oedema, Face Oedema, Laryngeal Oedema, Urticaria
Patient was taking Ultiva (View Usage). After Ultiva was administered, patient had the following side effects: eyelid oedema, face oedema, laryngeal oedema, urticaria on Jan 02, 2006 from FRANCE Additional patient health information: Female patient , 51 years of age, weighting 154.3 lb, . Ultiva dosage: . During the same period patient was treated with ZOPHREN (4mg Per Day) (View Zophren Review and Zophren Label ), TRACRIUM (View Tracrium Review and Tracrium Label ), ACUPAN (20mg Per Day) (View Acupan Review and Acupan Label ), MORPHINE (7mg Per Day) (View Morphine Review and Morphine Label ), BLEU PATENTE (View Bleu Patente Review and Bleu Patente Label ), PERFALGAN (View Perfalgan Review and Perfalgan Label ), DIPRIVAN (View Diprivan Review and Diprivan Label ). Patient was hospitalized.

4873411-8 | Heart Rate Increased, Pain, Unwanted Awareness During Anaesthesia
Adverse event was reported on Dec 13, 2005 by a Female patient taking Ultiva (View Usage) (Dosage: Bolus) was diagnosed with anaesthesia and. Location: GERMANY , 49 years of age, weighting 132.3 lb, Patient experienced the following unwanted or unexpected effects: heart rate increased, pain (What is pain?), unwanted awareness during anaesthesia.

4864471-9 | Heart Rate Increased, Pain, Unwanted Awareness During Anaesthesia
on Dec 13, 2005 Female patient from GERMANY , 49 years of age, was diagnosed with anaesthesia and was treated with Ultiva (View Usage). Patient had the following side effects: heart rate increased, pain (What is pain?), unwanted awareness during anaesthesia. Ultiva dosage: Bolus. During the same period patient was treated with PROPOFOL (Bolus) (View Propofol Review and Propofol Label ).

4814634-3 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Bilirubin Conjugated Increased, Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, Gamma-glutamyltransferase Increased, Hepatitis, Jaundice, Oedematous Pancreatitis
on Oct 13, 2005 Male patient from FRANCE , 23 years of age, was treated with Ultiva (View Usage). After Ultiva was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bilirubin conjugated increased, blood alkaline phosphatase increased, blood bilirubin increased, gamma-glutamyltransferase increased, hepatitis (What is hepatitis?), jaundice (What is jaundice?), oedematous pancreatitis. Ultiva dosage: . During the same period patient was treated with DIPRIVAN (View Diprivan Review and Diprivan Label ), PERFALGAN (View Perfalgan Review and Perfalgan Label ), CEFAZOLIN SODIUM (View Cefazolin Sodium Review and Cefazolin Sodium Label ), MORPHINE (View Morphine Review and Morphine Label ), AUGMENTIN '125' (View Augmentin '125' Review and Augmentin '125' Label ). Patient was hospitalized.

4804438-X | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Bilirubin Conjugated Increased, Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, Gamma-glutamyltransferase Increased, Hepatitis, Jaundice, Oedematous Pancreatitis
Patient was taking Ultiva (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, bilirubin conjugated increased, blood alkaline phosphatase increased, blood bilirubin increased, gamma-glutamyltransferase increased, hepatitis (What is hepatitis?), jaundice (What is jaundice?), oedematous pancreatitis on Oct 13, 2005 from FRANCE Additional patient health information: Male patient , 23 years of age, . Ultiva dosage: . During the same period patient was treated with DIPRIVAN (View Diprivan Review and Diprivan Label ), PERFALGAN (View Perfalgan Review and Perfalgan Label ), CEFAZOLIN SODIUM (View Cefazolin Sodium Review and Cefazolin Sodium Label ), MORPHINE (View Morphine Review and Morphine Label ), AUGMENTIN '125' (View Augmentin '125' Review and Augmentin '125' Label ). Patient was hospitalized.

4763661-3 | Blood Pressure Increased
Adverse event was reported on Apr 26, 2005 by a Female patient taking Ultiva (View Usage) (Dosage: Intravenous) was diagnosed with pain (What is pain?) and. Location: UNITED STATES , 51 years of age, weighting 190.0 lb, Patient had the following side effects: blood pressure increased. During the same period patient was treated with DESFLURANE (View Desflurane Review and Desflurane Label ), LEXAPRO (View Lexapro Review and Lexapro Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), GLUCOPHAGE (View Glucophage Review and Glucophage Label ), ISOSORBIDE MONONITRATE (View Isosorbide Mononitrate Review and Isosorbide Mononitrate Label ), NITROGLYCERIN (View Nitroglycerin Review and Nitroglycerin Label ), FENOFIBRATE (View Fenofibrate Review and Fenofibrate Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ).

4763660-1 | Blood Pressure Increased
on Apr 26, 2005 Female patient from UNITED STATES , 44 years of age, weighting 167.0 lb, was diagnosed with pain (What is pain?) and was treated with Ultiva (View Usage). After Ultiva was administered, patient had the following side effects: blood pressure increased. Ultiva dosage: Intravenous. During the same period patient was treated with DESFLURANE (View Desflurane Review and Desflurane Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ), CLOPIDOGREL BISULFATE (View Clopidogrel Bisulfate Review and Clopidogrel Bisulfate Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ).

4763656-X | Blood Pressure Increased
on Apr 26, 2005 Female patient from UNITED STATES , 77 years of age, weighting 136.0 lb, was diagnosed with pain (What is pain?) and was treated with Ultiva (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure increased. Ultiva dosage: Intravenous. During the same period patient was treated with DESFLURANE (View Desflurane Review and Desflurane Label ), LEXAPRO (View Lexapro Review and Lexapro Label ).

4715393-5 | Overdose, Tachycardia
Patient was taking Ultiva (View Usage). Patient had the following side effects: overdose, tachycardia on Jul 11, 2005 from UNITED STATES Additional patient health information: Female patient , 13 years of age, was diagnosed with analgesic effect and. Ultiva dosage: .